By accelerating the process of drug development, we reduce the cost and time taken to get the medicines to market.
Our platform allows medicines to be tested using our software, removing the need for unnecessary environmental impacts.
We help new medicines get to market quicker, making them more accessible so that they can improve the quality of lives of those who need it most.
Founder and Director
Mo Kosar is the Director of ConsoneAI, after having founded it in 2020.
Operations Director
Bruce Swan is the Operations Director of ConsoneAI.
Enter your email address below to register your interest.